TIRZEPATIDE ONE 10 mg

  • TirzepatideONE

TIRZEPATIDE ONE is a 10 mg peptide formulation developed by OMEGA ONE Pharmaceuticals, with a focus on purity, consistency, and stability for specialized research applications.

TIRZEPATIDE ONE 10 mg

TIRZEPATIDE ONE is a 10 mg peptide formulation developed by OMEGA ONE Pharmaceuticals, with a focus on purity, consistency, and stability for specialized research applications.

Product Overview

Tirzepatide ONE has generated significant scientific interest due to its dual activity at GIP and GLP-1 receptors, making it an important compound in contemporary metabolic research. TIRZEPATIDE ONE 10 mg brings this advanced peptide to the OMEGA ONE portfolio in a professional presentation for customers interested in metabolic signaling, glucose regulation, and energy-balance research.

Characteristics

  • Active Compound: Tirzepatide
  • Strength: 10 mg
  • Form: Lyophilized peptide
  • Mechanism Studied: Dual GIP and GLP-1 receptor agonist
  • Research Focus: Studied in metabolic research involving glucose regulation, insulin response, appetite signaling, energy balance, and body-weight regulation
  • Quality: High-purity formulation designed for consistency and stability
  • Brand: OMEGA ONE Pharmaceuticals
  • Storage: Store according to product specifications; refrigeration is generally required after reconstitution
  • Professional Use: Intended for specialized applications in accordance with applicable regulations

Presentation
1 vial of Lyophilized Powder
1 vial of Diluent – 3 mL

TirzepatideONE

Specific References